On the evening of January 16th, a notable trend emerged in China's A-share market as numerous publicly listed companies released earnings forecastsThe trend was overwhelmingly positive, with over 80% of these announcements reflecting an increase in earnings or a return to profitabilityAmong the standout performers was Prue Eye Hospital, which projected a staggering net profit increase of between 1163.98% and 1285.51% for 2023 compared to the previous yearOther companies also shared optimism with forecasts predicting year-on-year growth exceeding 100%.

Currently, there is a significant shift in perspective among foreign investment giants regarding Chinese assetsNed Bell, Chief Investment Officer of Bell Asset Management, a firm that has historically steered clear of Chinese stocks, has indicated a change in strategy

Advertisements

He is now considering investing in large Chinese technology firms, including Tencent HoldingsSimilarly, Abrdn, a global asset management company, has begun viewing the Chinese stock market as undervalued and is exploring options to establish protective positions through hedgesNoteworthy financial institutions like JP Morgan Asset Management and BlackRock have suggested that attractive valuations signal a potential rebound in Chinese assets.

Evidence suggests that foreign institutions aiming to go long on China may have already initiated actionData from Bloomberg indicated a sharp increase in options trading for the iShares China Large-Cap ETF, which tracks major Chinese companies listed in Hong KongTotal options volume surged to nearly 500,000 contracts last Wednesday, marking the second time within a month that it reached such elevated levels

Advertisements

Moreover, call options trading exceeded put options trading by more than double.

Additionally, Wang Chunying, Deputy Director and spokesperson for the State Administration of Foreign Exchange in China, has revealed that foreign investment intentions in the Chinese market are steadily increasingRecent months have seen a continued net increase in foreign holdings of domestic bonds, with a record net purchase of $24.5 billion in December aloneThis marks the fourth consecutive month of increased purchases of Renminbi-denominated bonds by foreign institutions, amounting to around 280 billion Yuan throughout 2023.

As a backdrop to these developments, on January 16th, multiple A-share companies announced their performance forecasts, with over 80% showing promising signs of growth or recovery according to Wind data

Advertisements

Prue Eye Hospital's forecast indicated an expected net profit of between 260 million and 285 million Yuan for 2023, translating to an extraordinary increase of over 1163%. This remarkable growth is attributed to the accelerated recovery of accumulated medical demand from the previous year, especially during the first half of 2023.

Jieshun Technology also announced an anticipated annual net profit of between 90 million and 135 million Yuan for 2023, which reflects a year-on-year growth of 396.07% to 644.11%. The company credited the rapid growth of its innovative services, such as parking cloud management and digital operations for parking lots, for this impressive performance.

Rui Ke Laser projected a net profit ranging from 200 million to 250 million Yuan in 2023, signaling a stellar growth of 389.32% to 511.64%. This surge is attributed to increased sales volume and revenue from laser products, alongside a significant improvement in gross margin.

Meanwhile, Zhongti Industry has estimated a net profit of approximately 66 million to 76 million Yuan for 2023, marking a year-on-year increase of 467% to 552%. Junsheng Electronics is forecasting a net profit of around 1.089 billion Yuan, representing a 176% increase compared to the previous year, fueled by recovery trends in major automotive markets and the rise of smart electric vehicles.

Also noteworthy, AVIC Xifei has projected a net profit of between 840 million and 940 million Yuan for 2023, which represents a growth of 61% to 80%. Companies like Tianrun Industrial and Dawson Group are similarly optimistic, projecting net profit increases of 90% to over 100% year-on-year, benefitting from strong demand in their respective sectors.

A significant change in outlook from foreign investors is evident

• U.S. Interest Rates Cut Again
• Avita Secures Over 11 Billion in Funding!
• Pinduoduo's Staggering Loss of Over 450 Billion!
• South Korean Stock Market Suffers Major Crash
• Euro Experiences Continuous Decline

Historically cautious investors now recognize value in Chinese equities, as highlighted by various analysts and fund managersWith valuations reaching historic lows, the MSCI China Index has dropped approximately 60% from its peak in 2021, now priced with a forward P/E below nine, contrasted starkly with India’s MSCI index at twelve and the S&P 500 at nineteen.

JP Morgan’s Asset Management has now shifted from a neutral stance on Chinese equities to an increasingly bullish one with their Global Multi-Asset Strategist, Sylvia Sheng, suggesting a strong potential for recovery as economic momentum stabilizesThis change aligns with Abrdn's recent strategy shift, as reflected by their interest in purchasing options to protect against a potential market upswing that could influence the performance of emerging market funds.

Similarly, BlackRock's Asia Pacific Investment Strategist, Thomas Taw, reinforces the notion that Chinese stock valuations appear increasingly favorable

Comments from William Yuen, the Chief Investment Officer at Invesco in Hong Kong, also suggest a keen interest in technology companies within China, especially as regulatory challenges begin to ease and firms find clarity in their operational environments.

These shifts in perspective from significant foreign asset management firms could potentially signal a monumental strategic transition for global investors looking to engage with Chinese stocksFurthermore, there have been indications that foreign institutions may have already begun actions to capitalize on this promising outlook for China.

January 17th marks the release of crucial macroeconomic data from the National Bureau of Statistics of China, with analysts predicting the GDP growth to maintain above 5% for 2023. The International Monetary Fund projects a 5.4% growth rate, positioning China as a leader among global economies